Delivery Order HHSN271201600004I-75N95018F00002
Award Date 9/6/18
Potential Completion Date 5/31/24
Potential Value $3.1M
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
Durham, NC 27705, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
2
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a Delivery Order under the "Phase I Clinical Trials for Development of Neurotherapeutics" Indefinite Delivery Indefinite Quantity (IDIQ) contract, awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Duke University. The contract is for administrative and overall clinical operations support under NIDA's Phase I clinical trials program for developing neurotherapeutics. The fixed-price delivery order has a ceiling value of $409,541.00 and a period of...
- This federal contract award is for a $109,969 Phase 1 Clinical Trial to be conducted by Duke University Office of Research Administration Division for the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases. The contract is a delivery order against the parent Therapeutics Against Infectious Diseases Phase 1 multiple-award IDIQ contract. Duke University, a private non-profit research university, is the prime...
- This is a $2,361,452.65 federal contract award to Duke University, a private non-profit university, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The contract is for a Phase 1 Clinical Trial Unit to develop therapeutics against infectious diseases. It is a delivery order placed under the Therapeutics Against Infectious Diseases Phase 1 indefinite delivery, indefinite quantity (IDIQ) contract. The contract has no...
- The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $1,281,164 cost-no-fee delivery order to Duke University's Office of Research Administration Division to conduct a Phase 1 clinical trial on therapeutics against infectious diseases. The order is part of a larger Therapeutics Against Infectious Diseases Phase 1 contract. No set-aside designation was used. Duke University is a private research university...
- This is a task order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Duke University. The task order is under the Early Phase Clinical Trial Units (EPCTU) indefinite delivery, indefinite quantity (IDIQ) contract vehicle. The award is for $1,963,927.00 and does not have a set-aside designation. The contract is for a cost-no-fee delivery order, with a period of performance extending to January 13, 2032. Duke University, a private...
- Duke University, as prime contractor, was awarded a $65,000 firm fixed price purchase order by the National Institutes of Health's National Institute of Child Health and Human Development to develop training in the principles, methods, and ethics of clinical research under the Clinical Research Reproductive Scientist Training program. The training is to be delivered in Durham, North Carolina over a one year period beginning in September 2014. No subcontractors or set aside designations were...
- Duke University, as prime contractor, is providing clinical research and immunization safety assessment services under a cost-no-fee delivery order valued at $489,565. This award is issued against the prime IDIQ contract held by Duke University from the Centers for Disease Control and Prevention, entitled "Phase I Clinical Trials for Development of Neurotherapeutics", with a potential value of $86 million through September 2028. No set-aside designation was used for this delivery...
- This is a federal contract award to Duke University, a private university and non-profit organization, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) under the U.S. Department of Health and Human Services (HHS). The contract is a Delivery Order under the "Therapeutics Against Infectious Diseases Phase 1" indefinite delivery/indefinite quantity (IDIQ) contract vehicle, with a ceiling value of $212,814.70....
- <p>Duke University, as prime contractor, is providing pediatric clinical trial services to the National Institutes of Health's National Institute of Child Health and Human Development under a cost-no-fee delivery order contract valued at $1,404,121.25. No set-aside designation was specified. Duke will conduct the work in Durham, North Carolina through July 31, 2020 to support the agency's mission of conducting and funding research on diseases and disorders affecting children.</p>
- This is a cost-no-fee Delivery Order contract awarded by the National Institute of Allergy and Infectious Diseases, a civilian agency, to Duke University for a Phase 1 Clinical Trial Unit for Therapeutics Against Infectious Diseases. The contract has a ceiling value of $416,539.69 and a period of performance through August 31, 2017. This order is part of a larger Therapeutics Against Infectious Diseases Phase 1 Indefinite Delivery Indefinite Quantity (IDIQ) contract vehicle. No set-aside...